CLINICAL_TRIALS
trial_result
· 2025-02-12
Clinical Trial Update: JAK Inhibitor Treatment in AGS [Phase 2]
Summary
Phase 2 trial of a JAK inhibitor in Aicardi-Goutières syndrome has completed, with results posted on 2025-02-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Adeline Vanderver, MD | Conditions: Aicardi Goutieres Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-02-12